Nanostructured Lipid Carrier Co-loaded with Doxorubicin and Docosahexaenoic Acid as a Theranostic Agent: Evaluation of Biodistribution and Antitumor Activity in Experimental Model-Reference-Cited by-同舟云学术

Nanostructured Lipid Carrier Co-loaded with Doxorubicin and Docosahexaenoic Acid as a Theranostic Agent: Evaluation of Biodistribution and Antitumor Activity in Experimental Model

Published:2017-10-17 Issue:3 Volume:20 Page:437-447
ISSN:1536-1632
Container-title:Molecular Imaging and Biology
language:en
Short-container-title:Mol Imaging Biol

Author:

Fernandes Renata S.,Silva Juliana O.,Mussi Samuel V.,Lopes Sávia C. A.,Leite Elaine A.,Cassali Geovanni D.,Cardoso Valbert N.,Townsend Danyelle M.,Colletti Patrick M.,Ferreira Lucas A. M.,Rubello Domenico,de Barros André L. B.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

http://link.springer.com/article/10.1007/s11307-017-1133-3/fulltext.html

Reference46 articles.

1. Stewart BW, Wild CP (2014) World cancer report 2014 latest world cancer statistics. International Agency for Research on Cancer, Lyon

2. Livi L, Meattini I, de Cardillo CL et al (2009) Non-pegylated liposomal doxorubicin in combination with cyclophosphamide or docetaxel as first-line therapy in metastatic breast cancer: a retrospective analysis. Tumori 95:422–426

3. Shi Y, Moon M, Dawood S et al (2011) Mechanisms and management of doxorubicin cardiotoxicity. Herz 36:296–305

4. Primeau AJ, Rendon A, Hedley D et al (2005) The distribution of the anticancer drug doxorubicin in relation to blood vessels in solid tumors. Clin Cancer Res 27:8782–8788

5. Trédan O, Galmarini CM, Patel K, Tannock IF (2007) Drug resistance and the solid tumor microenvironment. J Natl Cancer Inst 99:1441–1454

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Leveraging nanostructured lipid carriers to enhance targeted delivery and efficacy in breast cancer therapy: a comprehensive review;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-08-28

2. Lipid-Based Nanocarrier by Targeting with LHRH Peptide: A Promising Approach for Prostate Cancer Radio-Imaging and Therapy;Molecular Pharmaceutics;2024-06-26

3. Synergic Role of Dietary Bioactive Compounds in Breast Cancer Chemoprevention and Combination Therapies;Nutrients;2024-06-14

4. Omega-3 fatty acid supplementation attenuates intestinal mucositis and tumor growth in a murine model of breast cancer;Journal of Functional Foods;2024-04

5. A Detailed Insight into Nanostructured Lipid Carriers: A Versatile Drug Delivery System;Recent Patents on Nanotechnology;2023-12